Stay updated on IRX-2 Regimen and Durvalumab Clinical Trial
Sign up to get notified when there's something new on the IRX-2 Regimen and Durvalumab Clinical Trial page.

Latest updates to the IRX-2 Regimen and Durvalumab Clinical Trial page
- Check4 days agoChange DetectedThe page footer now shows a new revision label: Revision: v3.3.3. The HHS Vulnerability Disclosure link and the previous Revision: v3.3.2 label have been removed from the footer.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAdded a new version entry (34) in the Record History with an updated Study Status, reflecting the trial's latest state.SummaryDifference0.3%

- Check33 days agoChange DetectedThe Record History now includes a new revision entry for v3.3.2 and removes the v3.2.0 revision.SummaryDifference0.1%

- Check40 days agoChange DetectedThe government funding lapse notice was removed from the page; this administrative notice did not change the trial data or eligibility details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check54 days agoChange DetectedNew version entries appear in the Record History with updated Study Status and Recruitment Status, reflecting ongoing updates to the trial record. The overall layout remains unchanged.SummaryDifference0.1%

- Check83 days agoChange DetectedNew operating-status notice and version update to v3.2.0 are now present, replacing the previous v3.1.0; this adds important information about potential funding-related service limitations and where to check for status.SummaryDifference10%

Stay in the know with updates to IRX-2 Regimen and Durvalumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IRX-2 Regimen and Durvalumab Clinical Trial page.